Disclosure Plus

NuriFlex Acquitted in First-Instance Trial on Charges Including Violation of the Special Act on the Prevention of Corruption

Kwon Oh Seok
2026-11-03 14:37:04
[Edaily Reporter Kwon Oh Seok ] NuriFlex(040160)announced on the 3rd that it had been acquitted by the court of first instance on charges of fraud under the Act on the Aggravated Punishment of Specific Economic Crimes and violations of the Subsidy Management Act, for which it was indicted in 2023. However, relevant executives and employees were found guilty of bid-rigging.
According to the disclosure, in its first-instance ruling handed down on the 30th of last month, the Seoul Northern District Court acquitted Cho Song-man, the current CSO (Chief Strategy Officer) of NuriFlex, and former CEO Kim Young-deok of fraud charges under the Act on the Aggravated Punishment of Specific Economic Crimes. Furthermore, NuriFlex, along with CSO Cho Song-man and former CEO Kim Young-deok, who were indicted on charges of violating the Act on the Management of Subsidies, were all acquitted.
However, regarding the charges of bid-rigging, CSO Cho Song-man was sentenced to two years in prison (without immediate detention), while former Vice President Kim Han-soo and former Nurivista Director Yoo Sang-geun were each sentenced to one year in prison, suspended for two years. NuriFlex plans to appeal the first-instance ruling on the bid-rigging charges.

Economy

Corporation

IT·Science

Economy

Xcell Therapeutics Inc. Aims to Raise 8 Billion Won by Year-End… Will It Avoid the Risk of Negative Equity?

#Xcell Therapeutics Inc. is pursuing a third-party private placement worth 7 to 8 billion won to avoid the risk of negative equity by year-end. This comes after the company raised funds through a 9.5 …
2026-11-09 08:02:02

Corporation

Kim Dong-seon Launches Another Tender Offer for Hanwha M&S… Invests an Additional 27 billion won

Kim Dong-seon, President of Future Strategy at #Hanwha Machinery & Service Holdings (Hanwha M&S), is launching an additional tender offer for Hanwha M&S shares, investing approximately 27 billion won.…
2026-11-09 09:13:59

IT·Science

NIBEC CO., LTD. Pursues Global Technology Transfer Led by New Drugs for Obesity and Cardiovascular Diseases

NIBEC CO., LTD.(138610)is seeking to expand its collaboration with global pharmaceutical companies. The company plans to discuss partnerships focused on obesity treatments that simultaneously target b…
2026-11-09 10:49:02